Litecoin Enters Wall Street Territory With $100M Pharma Play

Description

A biotech company made a bold move. Based on reports, MEI Pharma announced a $100 million investment in Litecoin as part of its corporate treasury, backed by Titan Partners Group and broker firm GSR. Bold Bet For Litecoin According to a recent SEC filing, MEI Pharma acquired 29.24 million shares at $3.42 apiece through a PIPE deal, and it plans to funnel 100% of its net proceeds into LTC. The company also named Charlie Lee, Litecoin’s creator, to its board, a step that suggests MEI wants expert ...